Todd Franklin Watanabe - Jun 18, 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: President and CEO, Director
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Todd Franklin Watanabe
Stock symbol: ARQT
Transactions as of: Jun 18, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/22/2021, 06:35 PM
Previous filing: Jun 9, 2021
Next filing: Jul 8, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Other	$0	+7.38K	+14.76%	$0.00	57.4K	Jun 18, 2021	By LLC	F1, F2
holding	ARQT	Common Stock						595K	Jun 18, 2021	Direct	F3
holding	ARQT	Common Stock						17.9K	Jun 18, 2021	By Trust	F4
holding	ARQT	Common Stock						17.9K	Jun 18, 2021	By Trust	F5
holding	ARQT	Common Stock						125K	Jun 18, 2021	By Trust	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pro rata in-kind distribution from West Southwest Ventures LLC for no consideration.
F2	The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F3	Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
F4	The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F5	The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F6	The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.